NCT05949424 2023-11-29
OPTI-DOSE
University Medical Center Groningen
Phase 4 Unknown
Clinical Trials
5 trialsNCT05816642 2023-04-18
Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma
RenJi Hospital
Phase NA Unknown
NCT02324803 2014-12-24
Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients
Southern China Urology Cancer Consortium
Phase 2 Unknown
NCT02208128 2014-08-04
MORE
Heidelberg University
Phase NA Unknown
NCT01577784 2014-03-12
Pazopanib in Second-line Therapy in Renal Cell Carcinoma
Associació per a la Recerca Oncologica, Spain
Phase 2 Unknown